Rigetti Computing: Quantum Milestone Meets Market Doubts as Dilution Concerns Grow
Published on 07/15/2026 at 19:07 | Redaktion boerse-global.de
Rigetti Computing’s recent contract to supply a 108-qubit quantum computer to India’s CDAC research centre represents a tangible technical achievement, yet it has done little to arrest a sharp sell-off in the stock. The shares slid to €13.50 on Wednesday, cutting 4.4% from Tuesday’s close of €14.12, as investors weighed a promising order pipeline against an increasingly crowded share register and a revenue base that remains wafer-thin.
A Market Split Between Validation and Valuation
The CDAC deal is widely seen as proof that Rigetti’s modular chip design has reached commercial maturity. But the company’s fundamental numbers tell a different story: net losses for 2025 reached $216.2 million on revenue of just $7.09 million — a 34% drop from the prior year. Against that backdrop, the market capitalisation of roughly €4.8 billion yields a triple-digit price-to-sales ratio that even bullishly inclined analysts struggle to justify. Simply Wall St pegs the stock’s fair value at $16, only fractionally above last week’s close of $16.11, while a separate long-term assessment from the same house flags the equity as roughly 70% overvalued. By contrast, a consensus compiled by Pluang shows 85.7% of surveyed analysts with a buy rating and an average price target of $32.67 — implying upside of about 112% from current levels.
ATM Programme Adds to Share-Count Headaches
The widening gap between bulls and bears centres on Rigetti’s heavy reliance on equity-linked financing. Through its “at-the-market” (ATM) programme, the company has raised roughly $100 million by selling new shares directly into the market whenever the stock price ticks up. A further $100 million came in 2026 via a government quantum-funding grant that granted Washington an equity stake. Both moves have strengthened the balance sheet — cash and liquid securities stood at $569 million at the last quarter-end — but they also push up the share count, diluting existing holders. With revenue shrinking, the combination of a stretched valuation, falling top-line and steady dilution worries many market participants.
Should investors sell immediately? Or is it worth buying Rigetti?
Technicals Flash Caution Despite Short-Term Bounce
Price action over the past week underscores the stock’s fragility. After a five-day losing streak that erased roughly 12% of value, Rigetti managed a 4.9% rebound on 14 July, when a softer-than-expected US CPI print for June — monthly -0.4% and annual 3.5% — triggered a sector-wide relief rally that also lifted IonQ, D-Wave Quantum and Quantum Computing. That bounce proved short-lived. By Wednesday, the shares had given back those gains and were trading 23.3% below their 50-day moving average of €17.60 and 32.9% below the 200-day average of €20.13. The 14-day relative strength index of 35.4 signals that the stock is approaching oversold territory, yet the annualised 30-day volatility remains elevated at 84.2%.
Broader Macro and Sector Tailwinds Fail to Stick
The broader technology sector enjoyed a more constructive session on 15 July, lifted by strong earnings and an upgraded outlook from chip-equipment maker ASML, but Rigetti failed to join the advance. Analysts point to a confluence of macro headwinds — rising Middle East tensions, climbing oil prices and lingering questions about the commercialisation timeline for quantum computing — that have made investors increasingly selective. At a 72% discount to its 52-week high of €50.30 from October 2025, and having bounced just 22.8% off the March 2026 trough of €11.00, the stock remains caught between bargain hunters betting on a technical recovery and those waiting for hard evidence that the order pipeline can catch up with a stock price that has already priced in considerable success.
Ad
Rigetti Stock: New Analysis - 15 July
Fresh Rigetti information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
